PD-1/PD-L1 inhibitors associated hypophysitis: An analysis from the FAERS database and case reports-Reference-Cited by-同舟云学术

PD-1/PD-L1 inhibitors associated hypophysitis: An analysis from the FAERS database and case reports

Published:2024-02-29 Issue:1 Volume:18 Page:34-43
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Chen Shanshan¹,Ouyang Linqi²,Li Lian³,Xiao Yuyang⁴,Wang Shengfeng¹⁵

Affiliation:

1. Department of Pharmacy, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

2. Department of Pharmacy, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.

3. Department of Information, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

4. Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

5. Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Link

https://www.jstage.jst.go.jp/article/ddt/18/1/18_2023.01092/_pdf

Reference98 articles.

1. 1. Abril-Rodriguez G, Ribas A. SnapShot: Immune checkpoint inhibitors. Cancer Cell. 2017; 31:848-848.e1.

2. 2. Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer. 2019; 7:306.

3. 3. Shankar B, Zhang J, Naqash AR, et al. Multisystem immune-related adverse events associated with immune checkpoint inhibitors for treatment of non-small cell lung cancer. JAMA Oncol. 2020; 6:1952-1956.

4. 4. Seejore K, Giannoudi M, Osborn D, Lynch J, Al-Qaissi A, Dunwoodie E, Hook J, Marples M, Murray R. Characterisation of the onset and severity of adrenal and thyroid dysfunction associated with CTLA4-related hypophysitis. Eur J Endocrinol. 2021; 186:83-93.

5. 5. Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med. 2014; 6:230ra45.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avelumab/Camrelizumab/Durvalumab;Reactions Weekly;2024-04-27